Karin Dott
Impact in
- Virology top 1%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
Papers in
- Co-authors
- Marie Paule Kiény (10 shared papers)Yves Rivière (3 shared papers)Jean‐Pierre Lecocq (7 shared papers)Luc Montagnier (4 shared papers)Marc P Girard (4 shared papers)Andréa Pavirani (6 shared papers)Guy Champigny (2 shared papers)Wilfried Dalemans (2 shared papers)
- Journals
- Protein Engineering Design and Selection (4 papers)Nature (3 papers)Nature Biotechnology (2 papers)Virology (2 papers)Vaccine (1 paper)
- Partner nations
- FranceUnited KingdomUnited States
In The Last Decade
Karin Dott
24 papers receiving 2.0k citations
Karin Dott's Hit Papers
Peers
Comparison fields: 5 of 93
- Virology 798
- Infectious Diseases 389
- Pulmonary and Respiratory Medicine 570
- Immunology 379
- Hematology 128
Countries citing papers authored by Karin Dott
This map shows the geographic impact of Karin Dott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Dott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Dott more than expected).
Fields of papers citing papers by Karin Dott
This network shows the impact of papers produced by Karin Dott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Dott. The network helps show where Karin Dott may publish in the future.
Co-authors
The 25 scholars most cited alongside Karin Dott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Altered chloride ion channel kinetics associated with the ΔF508 cystic fibrosis mutation Hit paper breakdown → | 1991 | 615 |
| 2 | 1987 | 453 | |
| 3 | 1997 | 199 | |
| 4 | 1988 | 107 | |
| 5 | 1990 | 100 | |
| 6 | 1986 | 89 | |
| 7 | 2001 | 80 | |
| 8 | 1985 | 76 | |
| 9 | 1991 | 71 | |
| 10 | 1988 | 49 | |
| 11 | 1988 | 41 | |
| 12 | 1995 | 36 | |
| 13 | 1989 | 24 | |
| 14 | 1992 | 19 | |
| 15 | 2000 | 18 | |
| 16 | 1993 | 17 | |
| 17 | 1987 | 17 | |
| 18 | 1991 | 16 | |
| 19 | Recombinant MUC 1 vaccinia virus: a potential vector for immunotherapy of breast cancer. | 1994 | 15 |
| 20 | Directed cytokine expression in tumour cells in vivo using recombinant vaccinia virus. | 1994 | 11 |
About Karin Dott
Karin Dott is a scholar working on Virology, Genetics, Hematology, Epidemiology and Infectious Diseases, having authored 24 papers that have together received 2.1k indexed citations. Recurring topics across this work include Virus-based gene therapy research (9 papers), HIV Research and Treatment (7 papers), Hemophilia Treatment and Research (5 papers), Herpesvirus Infections and Treatments (4 papers), Hormonal Regulation and Hypertension (3 papers), HIV/AIDS drug development and treatment (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Virology (798 citations), Infectious Diseases (389 citations), Pulmonary and Respiratory Medicine (570 citations), Immunology (379 citations) and Hematology (128 citations). Karin Dott has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Marie Paule Kiény, Yves Rivière, Jean‐Pierre Lecocq, Luc Montagnier, Marc P Girard, Andréa Pavirani, Guy Champigny, Wilfried Dalemans, Michel Lazdunski and Pascal Barbry. Their work appears in journals such as Protein Engineering Design and Selection, Nature, Nature Biotechnology, Virology and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.